Home Authors Posts by Carmela Mendoza

Carmela Mendoza

Carmela Mendoza is a senior reporter for Private Equity International based in London. She first joined PEI in Hong Kong in 2015 and covered Asia. A graduate of Ateneo de Manila University, she previously worked for a digital agency in Singapore focused on government websites and publications covering business, trade and industry, transport, and social development.
For a successful ELTIF take-up, industry participants must strike a balance between flexible product rules and adequate investor protection.
Blue double exposure of coins stacked against a bar chart
NewVest seeks to change how investors gain exposure to private markets with the launch of its private markets index fund.
Illustration of a man stacking up gold coins beside an hourglass
While capital raising across strategies 'tends to ebb and flow, the overall path of travel is towards more alternatives', says Blackstone’s president and COO.
Headshots of Carlyle executives Marco De Benedetti, Jonathan Zafrani and Gregor Boehm
The firm’s Europe heads discuss portfolio diversification and how to manage evolution and generational change.
Healthcare and technology
Demographic shifts and the rising cost of care in Asia have boosted interest in the market, according to the SWF’s head of life sciences for direct investments in America.
LSE AIC 2023 PSP Investments
Private equity investors are set to benefit from a re-pricing of unprofitable businesses in an era of high interest rates, according to the pension manager’s global head of PE.
Crowds of people marching
The European giant aims to increase the share of private wealth capital in its closed-ended products, which stands at under 10%.
california sign against blue sky
The US’s biggest pension has taken a meaningful step towards making up for a lost decade of private equity returns.
An hourglass with the sand beginning to run out
GPs are navigating the toughest fundraising and investment conditions since the 2008 financial crisis.
Down arrows
The UK’s £34.6bn medical research endowment warns of difficult period ahead for private equity, marked by subdued distributions and longer fundraising cycles.

Copyright PEI Media

Not for publication, email or dissemination